The ultimate goal of the Company is to enter into the NASDAQ Small Cap Market after meeting the eligibility requirements through key Merger and Acquisitions. After Meridian's successful listing on the NASDAQ Small Cap Market, the investors will benefit from increased liquidity, secured exit strategies and increased value of their investment. 

Meridian is an established leader in the research,development, manufacturing, and marketing of integrative medical devices in the healthcare industry. Integrative medicine combines both Eastern and Western expertise in order to obtain the highest quality and standard. Established in 1994 in South Korea, Meridian became listed on the OTC Bulletin Board under the symbol OTCBB:MRDAF on February 13, 2002. The company has grown substantially and has established subsidiaries in China, Los Angeles, and a corporate distribution office in Vancouver, BC. With over 13 million dollars in revenue to date, Meridian continues to expand and secure its position as a global leader of integrative medical devices.

With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 15 technology design and patents and has received 6 FDA approvals for their medical devices. In order to distribute worldwide, Meridian has also gained 4 CE approvals in Europe,2 SDA approvals in China, and 4 FIP approvals in South America. Successfully marketed in Korea, USA, Canada, China and Europe, Meridian continues to provide its superior product line to a growing number of clients worldwide. Meridian has over 1500 clients which include physicians, hospitals, healthcare professionals, medical device manufacturers, and health and fitness centers